Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
106 studies found for:    cancer | butyrate
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Completed Ganciclovir Plus Arginine Butyrate in Treating Patients With Cancer or Lymphoproliferative Disorders Associated With the Epstein Barr Virus
Conditions: Leukemia;   Lymphoma;   Precancerous Condition;   Small Intestine Cancer
Interventions: Drug: arginine butyrate;   Drug: ganciclovir
2 Terminated Study of HQK-1004 and Valganciclovir to Treat Epstein-Barr Virus (EBV) - Positive Lymphoid Malignancies or Lymphoproliferative Disorders
Conditions: Lymphoid Malignancies;   Lymphoproliferative Disorders
Interventions: Drug: HQK-1004;   Drug: Valganciclovir (may substitute with ganciclovir)
3 Completed Tributyrin in Treating Patients With Refractory Prostate Cancer or Other Solid Tumors
Conditions: Prostate Cancer;   Unspecified Adult Solid Tumor, Protocol Specific
Interventions: Drug: chemotherapy;   Drug: tributyrin
4 Completed Effect of Annona Muricata Leaves on Colorectal Cancer Patients and Colorectal Cancer Cells
Condition: Colorectal Cancer
Interventions: Dietary Supplement: Annona muricata extract;   Dietary Supplement: Placebo
5 Terminated Study of Arginine Butyrate and Ganciclovir/Valganciclovir in EBV(+) Lymphoid Malignancies
Conditions: EBV Lymphomas;   Lympho-proliferative Diseases
Interventions: Drug: Arginine Butyrate;   Drug: Ganciclovir;   Drug: Valganciclovir
6 Recruiting Microbiome, Exercise Tracking Study (METS)
Condition: Colorectal Cancer
Intervention: Behavioral: Physical activity intervention
7 Completed
Has Results
A Pilot Study to Evaluate Efficacy and Safety of Clevidipine in Neurosurgical Patients
Conditions: Hypertension;   Brain Tumor;   Epilepsy
Intervention: Drug: Clevidipine
8 Recruiting Relaxation for Women With Breast Cancer Undergoing Radiotherapy
Condition: Breast Cancer
Interventions: Other: Relaxation Program;   Behavioral: Questionnaires;   Other: Saliva Testing
9 Active, not recruiting Mindfulness Based Couples Therapy
Condition: Breast Cancer
Interventions: Behavioral: Mindfulness-Based Relationship Enhancement (MBRE);   Behavioral: Self-Help Materials;   Behavioral: Pain Assessment;   Behavioral: Questionnaires;   Behavioral: Neurocognitive Tests;   Procedure: Cortisol Tests;   Behavioral: Interviews
10 Completed Ketoconazole, Hydrocortisone, and GM-CSF in Treating Patients With Progressive Prostate Cancer After Hormone Therapy
Condition: Prostate Cancer
Interventions: Biological: sargramostim;   Drug: ketoconazole;   Drug: therapeutic hydrocortisone
11 Terminated
Has Results
Saracatinib in Treating Patients With Prostate Cancer
Conditions: Hormone-resistant Prostate Cancer;   Recurrent Prostate Cancer;   Stage IV Prostate Cancer
Interventions: Drug: saracatinib;   Other: hydrocortisone/placebo
12 Completed
Has Results
Gemcitabine Hydrochloride With or Without Vismodegib in Treating Patients With Recurrent or Metastatic Pancreatic Cancer
Conditions: Adenocarcinoma of the Pancreas;   Recurrent Pancreatic Cancer;   Stage IV Pancreatic Cancer
Interventions: Drug: vismodegib;   Drug: gemcitabine hydrochloride;   Other: hydrocortisone/placebo
13 Terminated A Phase II Trial of Early Medical Adrenalectomy for "D0.5" Prostate Cancer
Condition: Prostate Cancer
Interventions: Drug: aminoglutethimide;   Drug: ketoconazole;   Drug: therapeutic hydrocortisone
14 Completed Antiandrogen Withdrawal in Treating Patients With Hormone-Refractory Prostate Cancer
Condition: Prostate Cancer
Interventions: Drug: ketoconazole;   Drug: therapeutic hydrocortisone;   Other: Withdrawal of antiandrogen therapy
15 Completed Hormone Therapy Compared With Combination Chemotherapy in Treating Patients With Prostate Cancer
Condition: Prostate Cancer
Interventions: Drug: docetaxel;   Drug: estramustine phosphate sodium;   Drug: ketoconazole;   Drug: therapeutic hydrocortisone
16 Active, not recruiting Celecoxib in Treating Patients With Cervical Intraepithelial Neoplasia
Conditions: Cervical Cancer;   Cervical Intraepithelial Neoplasia Grade 2;   Cervical Intraepithelial Neoplasia Grade 3
Interventions: Other: hydrocortisone/placebo;   Drug: celecoxib
17 Withdrawn Ketoconazole, Dexamethasone, and Hydrocortisone in Treating Patients With Prostate Cancer That Did Not Respond to Androgen-Deprivation Therapy
Condition: Prostate Cancer
Interventions: Drug: dexamethasone;   Drug: ketoconazole;   Drug: therapeutic hydrocortisone;   Procedure: pharmacological study
18 Recruiting Effect of Dexmedetomidine on Plasmatic Cortisol Response in Transsphenoidal Surgery
Condition: Pituitary Neoplasms
Interventions: Drug: Dexmedetomidine;   Drug: Sodium Chloride 0.9%
19 Terminated Ketoconazole, Hydrocortisone, Dutasteride and Lapatinib (KHAD-L) in Prostate Cancer
Condition: Prostate Cancer
Interventions: Drug: ketoconazole;   Drug: hydrocortisone;   Drug: dutasteride;   Drug: lapatinib
20 Completed Flutamide, Suramin, and Hydrocortisone in Treating Patients With Prostate Cancer
Condition: Prostate Cancer
Interventions: Drug: flutamide;   Drug: goserelin acetate;   Drug: leuprolide acetate;   Drug: suramin;   Drug: therapeutic hydrocortisone;   Procedure: orchiectomy

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.